IXA is a network, servicedesk and liaison, all in one.
We offer researchers the expertise of grant advisers, business developers and legal experts to help determine a valorisation/ impact strategy. We assist in setting up collaborations with third parties and/or starting new ventures, while managing intellectual property and other legal and financial support. For researchers to develop their skills on valorisation and entrepreneurship, IXA organises workshops, courses and masterclasses on a regular basis. Go to For researchers for more information or have a look at our Workshops & Events page.
For companies, non-profits, governments, health care and educational institutions, etc., we provide a gateway to research expertise, high-tech facilities and research infrastructure, contract research, collaboration and investment opportunities. Go to For companies/non-profits to find out more.
Next to offering a wide range of services, we closely cooperate with other parties within the Amsterdam innovation landscape. When opportunities arise, IXA takes the lead in developing programs and activities to further stimulate economic activity and entrepreneurship in research and education.
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News